EmbryoSure The Next Generation PGT-A Screening Services

EmbryoSure is an advanced AI-enabled PGT-A screening solution that improves embryo selection accuracy and supports better IVF outcomes.
Book a Consultation
A vector banner image of a man discussing with a medical professional for assessing male reproductive genetic health.
A vector image illustrating sperm DNA fragmentation.

Understanding the EmbryoSure Difference

Standard PGT-A (PGS) typically only checks the number of chromosomes. Within our Preimplantation Genetic Testing framework, EmbryoSure is a proprietary solution that integrates two powerful technologies, Copy Number Variation (CNV) and Single Nucleotide Polymorphism (SNP) analysis using advanced Next-Generation Sequencing (NGS).

Performed as an EmbryoSure test in our clinical genetic lab, this dual-layer approach allows us to detect complexities that standard tests often miss — helping to identify embryos with higher genetic viability.

Understanding the Origin of Aneuploidy

Aneuploidy is a condition in which a cell has an abnormal number of chromosomes, and it is one of the leading causes of implantation failure and miscarriage in IVF.

Unlike standard PGT-A, EmbryoSure goes a step further by analysing the origin of aneuploidy — identifying whether the chromosomal abnormality arises from the maternal or paternal side. This is enabled through advanced SNP-based analysis that provides deeper insight into chromosomal patterns beyond standard screening.

Understanding where aneuploidy originates provides deeper clinical insight into the underlying causes of poor embryo development. It helps fertility specialists tailor treatment strategies, optimise stimulation protocols, and make more informed decisions for future IVF cycles.

By moving beyond detection to interpretation, EmbryoSure enables a more precise and personalised approach to embryo selection and fertility care.

A vector image illustrating sperm DNA fragmentation.

Who is EmbryoSure Recommended For?

While EmbryoSure is beneficial for any couple undergoing IVF, it is highly recommended as part of our PGT-A screening services in the following cases:
Advanced Maternal Age (35+)
To screen for the higher incidence of chromosomal abnormalities.
Recurrent Implantation Failure
For couples who have had multiple unsuccessful IVF cycles.
Recurrent Miscarriage
To identify the genetic causes behind repeated pregnancy loss.
Severe Male Factor Infertility
When sperm quality may impact the genetic integrity of the embryo.
Previous Aneuploid Pregnancy
For couples who have previously had a pregnancy affected by a chromosomal syndrome.

The EmbryoSure Process

The EmbryoSure test leverages proprietary algorithms and AI to provide a deeper look into the genetic makeup of your embryos.

Dual-Method Analysis (CNV + SNP)

While standard tests only look at chromosome count, EmbryoSure analyzes over 500 SNPs (genetic markers) alongside traditional screening. This increases detection accuracy for small chromosomal changes and ensures a more reliable "Euploid" (healthy) result.
01
02
Standard PGT-A can sometimes misidentify embryos with an entire extra or missing set of chromosomes (polyploidy). EmbryoSure’s SNP-based technology accurately identifies these abnormalities — preventing the transfer of non-viable embryos that would otherwise lead to miscarriage.

Precise Haploid & Triploid Detection

Maternal Cell Contamination (MCC) Screening

One of the biggest risks in genetic testing is the accidental presence of the mother’s cells in the biopsy sample. EmbryoSure includes a proprietary contamination check — ensuring the results reflect the embryo’s genetics, not the mother’s.

03
04
A unique safety feature that confirms embryos belong to the same genetic pool — providing parents with absolute peace of mind regarding the security and handling of their precious samples at our advanced PGT-A testing centre.

Sibling & Genetic Pool Verification

A DNA Structure
An inquiry for a Male Reproductive Genetic Health testing appointment is illustrated.

Ready for a Smarter Path to Parenthood?

Don’t just transfer—transfer with certainty.
Discover how EmbryoSure can transform your fertility journey with unmatched genetic clarity.
Consult Our Genetics Team

Benefits of EmbryoSure

Choosing the right embryo is the most critical step in an IVF cycle. Through our PGT-A screening services, EmbryoSure is designed to provide better outcomes through scientific precision.
By selecting truly healthy embryos, we avoid the unsuccessful transfer of non-viable ones.
Detects complex chromosomal sets (like triploidy) that standard PGT-A often misses — significantly lowering the risk of early pregnancy loss.
Traditional methods often discard embryos with abnormal fertilization (0PN/1PN/3PN). EmbryoSure can identify which of these are actually genetically normal, potentially increasing the number of embryos available for transfer.
Because of its high accuracy, clinicians can confidently transfer one single embryo — reducing the medical risks associated with twin or multiple pregnancies.